Assessment of SpondyloArthritis International Society (ASAS) Consensus on Spanish Nomenclature for Spondyloarthritis.

Consenso ASAS en nomenclatura en español para las espondiloartritis.

Journal

Reumatologia clinica
ISSN: 2173-5743
Titre abrégé: Reumatol Clin (Engl Ed)
Pays: Spain
ID NLM: 101717526

Informations de publication

Date de publication:
Historique:
received: 08 05 2018
revised: 19 07 2018
accepted: 24 07 2018
pubmed: 9 9 2018
medline: 9 7 2021
entrez: 9 9 2018
Statut: ppublish

Résumé

To develop a consensus to standardize the use of Spanish terms, abbreviations and acronyms in the field of spondyloarthritis (SpA). An international task force comprising all native Spanish-speaking Assessment of SpondyloArthritis International Society (ASAS) members, the executive committee of Grupo para el estudio de la Espondiloartritis de la Sociedad Española de Reumatología (GRESSER), two methodologists, two linguists from the Real Academia Nacional de Medicina de España (RANM) and two patients from the Spanish Coordinator of Spondylitis Associations (CEADE) was established. A literature review was performed to identify the conflicting terms/abbreviations/acronyms in SpA. This review examined written sources in Spanish including manuscripts, ICF and ICD, guidelines, recommendations and consensuses. This was followed by a nominal group meeting and a three-round Delphi. The recommendations from the RANM based on the Panhispanic dictionary were followed throughout the process. Consensus was reached for 46 terms, abbreviations or acronyms related to the field of SpA. A Spanish translation was accepted for 6 terms and 6 abbreviations to name or classify the disease, and for 6 terms and 4 abbreviations related to SpA. It was agreed not to translate 15 acronyms into Spanish. However, when mentioning them, it was recommended to follow this structure: type of acronym in Spanish and acronym and expanded form in English. With regard to 7 terms or abbreviations attached to acronyms, it was agreed to translate only the expanded form and a translation was also selected for each of them. Through this standardization, it is expected to establish a common use of the Spanish nomenclature for SpA. The implementation of this consensus across the community will be of substantial benefit, avoiding misunderstandings and time-consuming processes.

Identifiants

pubmed: 30193774
pii: S1699-258X(18)30173-6
doi: 10.1016/j.reuma.2018.07.014
pii:
doi:

Types de publication

Consensus Development Conference Journal Article

Langues

eng spa

Sous-ensembles de citation

IM

Pagination

333-338

Informations de copyright

Copyright © 2018 Elsevier España, S.L.U. and Sociedad Española de Reumatología y Colegio Mexicano de Reumatología. All rights reserved.

Auteurs

Victoria Navarro-Compán (V)

Hospital Universitario La Paz, IdiPaz, Madrid, España. Electronic address: mvictoria.navarroc@gmail.com.

Teresa Otón (T)

Instituto de Salud Musculoesquelética, Madrid, España.

Estíbaliz Loza (E)

Instituto de Salud Musculoesquelética, Madrid, España.

Raquel Almodóvar (R)

Hospital Universitario Fundación Alcorcón, Madrid, España.

Rafael Ariza-Ariza (R)

Hospital Universitario Virgen Macarena, Sevilla, España.

Wilson Bautista-Molano (W)

Universidad Militar Nueva Granada, Bogotá, Colombia.

Rubén Burgos-Vargas (R)

Hospital General de México, Ciudad de México, México.

Eduardo Collantes-Estévez (E)

Hospital Universitario Reina Sofía, IMIBIC, Universidad de Córdoba, Córdoba, España.

Eugenio de Miguel (E)

Hospital Universitario La Paz, IdiPaz, Madrid, España.

Carlos González-Fernández (C)

Hospital General Universitario Gregorio Marañón, Madrid, España.

Jordi Gratacós (J)

Hospital Universitario Parc Taulí de Sabadell, I3PT, Universitat Autònoma de Barcelona (UAB), Barcelona, España.

Sebastián Ibáñez (S)

Facultad de Medicina Clínica Alemana-Universidad del Desarrollo, Santiago de Chile, Chile.

Xavier Juanola (X)

Hospital Universitario de Bellvitge, IDIBELL, Universitat de Barcelona, Barcelona, España.

Jose Maldonado-Cocco (J)

Facultad de Medicina, Universidad de Buenos Aires, Buenos Aires, Argentina.

Anna Moltó (A)

Hôpital Cochin Hospital, Assistance Publique Hôpitaux de Paris-INSERM (U1153): Clinical Epidemiology and Biostatistics, PRES Sorbonne Paris-Cité, París, Francia.

Juan Mulero (J)

Hospital Universitario Puerta de Hierro, Majadahonda, Madrid, España.

Cesar Pacheco-Tena (C)

Universidad Autónoma de Chihuahua, Chihuahua, México.

Cesar Ramos-Remus (C)

Unidad de Investigación en Enfermedades Cronicodegenerativas, Ciudad de México, México.

Jesús Sanz-Sanz (J)

Hospital Universitario Puerta de Hierro, Majadahonda, Madrid, España.

Rafael Valle-Oñate (R)

Clínica Colombiana de Reumatología-Salud Reinun, Colombia.

Pedro Zarco (P)

Hospital Universitario Fundación Alcorcón, Madrid, España.

Helena Marzo-Ortega (H)

NIHR Biomedical Research Centre, Leeds Teaching Hospitals Trust and Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, Reino Unido.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH